VENUSREMNSEVenus Remedies Limited· PharmaceuticalsMinimalNeutral
Announced Wed, 8 Apr · 10:27 IST

Venus Remedies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 under Reg 74(5) for the quarter ended on 31st March 2026

VENUSREM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+5.8%1-day move
₹915.00
prior close
₹961.10
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+5.8+8.5+13.4+16.1+13.7+11.8+5.6+11.1+79.9+87.1
Up moveDown movePending
AI summary

Venus Remedies Limited has submitted a quarterly compliance certificate under SEBI Regulation 74(5) for the January–March 2026 quarter. The certificate was issued by its Registrar and Transfer Agent, MUFG Intime India Pvt Ltd (formerly Link Intime). It confirms that all share certificates received for dematerialisation during the quarter were processed, and the corresponding physical certificates were mutilated and cancelled after due verification. The RTA also confirmed that the depository's name has been substituted as the registered owner in the company's member records within SEBI's prescribed timelines.

Likely market impact

This is a routine regulatory compliance filing with no material impact on the business, financials, or share price. It simply confirms that the company's share dematerialisation process is working as required by SEBI rules.